Analystreport

Strongbridge Biopharma plc (NASDAQ: SBBP) had its "buy" rating re-affirmed by analysts at Jefferies Financial Group Inc. They now have a $5.00 price target on the stock.

Strongbridge Biopharma plc - Ordinary Shares  (SBBP) 
Last strongbridge biopharma plc - ordinary shares earnings: 2/25 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investors.strongbridgebio.com/investor-overview